Whalegun
Lobbying

DBV Technologies's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $100K. Its first report covers Q2 2024; the issues it reports most are Health Issues.

DBV Technologies

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$100K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

DBV Technologies lobbying by quarter
DBV Technologies lobbying by quarter
QuarterAmountReports
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$30K1
Q2 2026$30K1
Q3 2026$00

By issue

  • Health issues$340K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Food & Drug Administration (FDA)3 reports

Firms it paid

Firm
Winning Strategies Washington$340K9 quarters

Former officials lobbying for it

Former position
DONNA MULLINSCoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator ChiesaQ2 2026
ELIZABETH CONNOLLYAssistant Director of the Office of Public Health, Office of National Drug Control PolicyQ2 2026
MICHAEL A MEROLADeputy CoS, Sen. TorricelliQ2 2026

Lobbying reports

Filed by
07/16for Q2Winning Strategies Washington$30K
04/17for Q1Winning Strategies Washington$30K
01/19for Q4 2025Winning Strategies Washington$40K
25/10/19for Q3 2025Winning Strategies Washington$40K
25/07/20for Q2 2025Winning Strategies Washington$40K
25/04/17for Q1 2025Winning Strategies Washington$40K
25/01/20for Q4 2024Winning Strategies Washington$40K
24/10/14for Q3 2024Winning Strategies Washington$40K
24/07/23for Q2 2024Winning Strategies Washington$40K
24/07/22for Q2 2024Winning Strategies WashingtonUnder $5,000